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Female vaginal contraceptives are associated with increased susceptibility to infections. The prevalence of female 
reproductive tract infections (RTI) among contraceptive users was determined. A total of 187 female participants 
including 156 contraceptive users and 31 age-matched noncontraceptive users with signs and symptoms of RTIs were 
recruited for this study. A questionnaire was used to collect demographic information. High vaginal swabs were col-
lected from each participant and processed using standard technique. Female contraceptive users (40.4%) had an 
increased risk for developing RTIs compared to noncontraceptive users (19.35%) (OR = 2.833, 95 CI = 1.095, 7.276; 
p = 0.044). Intrauterine device (IUD) users (53.07%; p = 0.032), users of contraceptives for less than 1 year (60.00%; 
p = 0.003) and age group of 26−30 years (68.18%; p = 0.0001) had significantly higher prevalence of RTIs among contra-
ceptive users. Candida albicans was the most prevalent etiologic agent of RTIs among contraceptive users irrespec-
tive of types of contraceptives, bacteria vaginosis caused by other bacterial isolates was the most common RTIs 
among noncontraceptive users. In this situation, Klebsiella species was found only among IUD users. The study reveals 
an overall prevalence of 36.90% of female RTIs. Contraceptive users had 1−7 fold increase in developing RTIs. Vaginal 
candidiasis and bacterial vaginosis were the most common female RTIs observed among contraceptives and noncon-
traceptive users. Some valuable measures to reduce infections associated with contraceptive use are advocated.
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Introduction
It is estimated that 340 millions of new cases of 
curable sexually transmitted infections occur each 
year in women and men suffering from reproduc-
tive tract infections (RTIs).1 RTIs are the top five 
infectious disease in adults seeking health care, and 
about one third of RTIs occur globally among people 
younger than 25 years of age.2
In developing countries, it has been reported that 
over 700,000 maternal deaths are associated with 
unintended pregnancies, and more than 400,000 
of those deaths resulting from their unsafe abor-
tions.3 In general, contraceptive methods are used 
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to prevent sexually transmitted infections and 
unwanted pregnancies.
Sexually transmitted disease and pelvic inflam-
matory disease (PID) resulting from inappropriate 
contraceptive method may cause infertility.4 Cer-
tain contraceptives methods have been reported 
to increase host susceptibility to infections.5 The 
complications of RTIs arising from the use of contra-
ceptive methods indicate the urgent need for safe 
and effective tools of contraceptives. The control of 
RTIs, especially sexually transmitted infections, is an 
urgent health priority in many countries.6 This study 
aims to determine the prevalence of RTIs among fe-
males using various contraceptive methods as well 
as their etiologic agents in Benin City, Nigeria.
Materials and Methods
Study population
A total of 187 female participants consisting of 156 
contraceptive users and 31 age-matched noncon-
traceptive users control groups were recruited for 
this study. All participants had signs and symptoms 
of reproductive tract infections (RTIs).
Demographics, types of contraceptives and dura-
tion of contraceptive use were obtained with the 
aid of questionnaire. The contraceptive users were 
attending family planning clinic while controls 
were attending the Gynaecology Clinic, both in the 
University of Benin Teaching Hospital, Benin City, 
Nigeria from August 2006 to August 2008. Verbal 
informed consent was obtained from each patient 
prior to specimen collection. The study was approved 
by the Ethical Committee of the University of Benin 
Teaching Hospital.
Collection and processing of sample
A pair of high vaginal swab were collected from each 
patient and transported to the laboratory for anal-
ysis within 1 hour. One swab was used to make film 
for Gram staining. The other swab was inoculated 
onto chocolate agar, Blood agar, MacConkey agar 
and Sabourand agar for 24−48 hours. Bacterial vagi-
nosis caused by other bacterial isolates was diag-
nosed using Nugent’s Gram stain scoring system. 
Trichomonas vaginalis was identified by its typical 
morphology and motility on wet mount of high 
vaginal swab. Candidiasis was diagnosed by the 
presence of yeast-like cell in wet mount as well as 
fungal culture. Gonorrhoea was diagnosed by the 
presence of intracellular Gram negative diplococci 
and/or identification of bacterial culture. Bacterial 
isolates were identified using standard laboratory 
techniques.7
Statistical analysis
The data obtained were analyzed using the χ2 test 
and odds ratio (OR) by using the statistical soft-
ware InStat (GraphPad Software, Inc., La Jolla, 
CA, USA).
Results
The effect of demographics on the prevalence of 
female RTIs among users of contraceptives is shown 
in Table 1. A total of 69 (36.90%) of the 187 patients 
had RTIs. Females that used contraceptives (40.38%) 
were at an increase risk of acquiring RTIs (OR = 2.833, 
95% CI = 1.095, 7.276, p = 0.044). Female patients 
using IUD had significantly (p = 0.032) higher preva-
lence of RTIs compared with those that used other 
methods. The longer the use of contraceptives, the 
lower the prevalence of RTIs as the prevalence fell 
from 60% for the less-than-1-year users to 10% for 
the 11−15-year users. This was statistically significant 
(p = 0.003). The prevalence of RTIs among female 
contraceptive users was significantly (p < 0.0001) 
higher in the age group of 26−30 years (68.18%).
In RTIs, Candida albicans was the most prevalent 
agents among different methods of contraceptive 
users. It was also the only isolate among spermicidal 
condom user. Klebsiella species and Staphylococcus 
aureus were only recovered from IUD and inject-
able users respectively (Table 2).
Discussion
Genital and urinary tract diseases due to contra-
ceptive methods contributed to the sequelae of 
infertility, ectopic pregnancy, PID and its higher 
mortality and morbidity rates among neonates and 
their mothers.8 This study focused on determining 
the prevalence of RTIs among women using various 
contraceptive methods as well as nonusers. The ef-
fect of demographics on prevalence and etiologic 
agents were also determined.
A total of 69 (36.90%) of the 187 participants had 
RTIs. This was lower than that of data previously 
reported.9 The difference could be because of the 
source of patients used in this study; we included 
only out-patients attending the Obstetrics and 
Gynaecology, and Antenatal Clinics. However, the 
participants in data of Omoregie et al9 report in-
cluded both in and out-patients.
Females using various contraceptive methods had 
approximately 1−7 fold increase in risk of acquir-
ing RTIs compared to noncontraceptive users. This 
agrees with other previous reports.8,10 Procedures 
for manipulations of contraceptive methods in female 
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genital tract is well known to increase the risk for 
female genital tract infections.10
The prevalence of RTIs is higher in IUD users than 
that of other contraceptive methods. This agrees 
with other previous reports.6 The procedure of in-
sertion of IUD is not an aseptic method which may 
push vaginal and cervical bacteria into the uterus 
from the tail of the device.5
The results in this study indicate that the longer 
the uses of contraceptive methods, the lower the 
prevalence of RTIs. This result was significant (p = 
0.003). There is an increased chance of infections 
among contraceptive users, particularly IUD users, 
within the first few weeks of use.5,11 Contraceptive 
methods with the use of hormone have been reported 
to lower immunity.12 It is possible to reduce immu-
nity and give rise to RTIs during the early weeks of 
contraceptive usage. As the duration of contracep-
tive usage increases, the body may be developing 
the immunity needed to increase the ability against 
invading microorganisms and reducing the preva-
lence of female RTIs. This condition may explain the 
findings obtained in this study.
The highest prevalence of female RTIs among con-
traceptive users was significantly (p < 0.0001) af-
fected by age in the group of 26−30-year-olds. The 
reason behind this requires further studies. The level 
of education of female contraceptive users did not 
significantly affect the prevalence of RTIs among con-
traceptive users, although the prevalence increases 
Table 1 Effect of demographics on the prevalence of reproductive tract infections among contraceptives users
Characteristics No. tested No. infected (%) OR  95% CI p
Participants
 On contraceptives  156 63 (40.38) 2.833 1.095, 7.276
 Control 31 6 (19.85) 0.354 0.137, 0.913 0.044
Types of contraceptive
 Injectable  81 25 (32.10)
 Intrauterine device 54 29 (53.70)
 Pills 14 7 (50.00)
 Spermicidal condoms 7 1 (14.29)   0.032
Level of education
 None  7 2 (28.57)
 Primary  49 15 (30.16)
 Secondary  75 32 (42.67)
 Tertiary  25 14 (56.00)   0.169
Duration of use of contraceptive (yr)
 < 1 30 18 (60.00)
 1−5  102 42 (41.18)
 6−10  14 2 (14.29)
 11−15  10 1 (10.00)   0.003
Age (yr)
 21−25  9 0 (0.00)
 26−30 44 30 (68.18)
 31−35 25 7 (28.00)
 36−40 39 16 (41.03)
 41−45 39 10 (25.64)   < 0.0001
OR: odds ratio; CI: confidence interval.
Table 2 Microbial isolates of reproductive tract infection among users of various contraceptive methods
 Prevalence of microbial isolates in types of contraceptives (%)
Isolate
 Injectable Intra-uterine device Pills Spermicidal condoms 
Total (%)
Klebsiella species  0 (0.00) 2 (6.00) 0 (0.00) 0 (0.00) 2 (3.17)
Staphylococcus aureus 1 (3.85) 0 (0.00) 0 (0.00) 0 (0.00) 1 (1.59)
Other bacterial isolates 9 (34.62) 9 (31.03) 1 (14.29) 0 (0.00) 19 (30.16)
Candida albicans  15 (57.69) 16 (55.17) 6 (85.71) 1 (100.00) 38 (60.32)
Trichomonas vaginalis 1 (3.85) 2 (6.90) 0 (0.00) 0 (0.00) 3 (4.76)
Total  26 (41.27) 29 (46.03) 7 (11.11) 1 (1.59) 63
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from those with no formal education (28.6%) to 
those with tertiary level of education (56.0%). IUD 
users had more complex microbial isolates, followed 
by injectable users, pills and spermicidal condom 
users. C. albicans was the only isolate recovered 
from spermicidal condom users and Klebsiella spe-
cies were recovered from only IUD users. Notably, 
Staphylococcus aureus isolated was recovered from 
the injectable users. Trichomonas vaginalis was not 
isolated from pills and spermicidal condom users. 
Interestingly, bacterial vaginosis infected with other 
bacteria was not identified from spermicidal condom 
users. Generally C. albicans was the predominant mi-
crobial agent causing female RTIs among contracep-
tive users irrespective of methods of contraception.
The high prevalence of C. albicans among oral 
contraceptive users had previously been noted.8 The 
increased rate of infection with C. albicans among 
female oral contraceptive users is believed to be 
due to the effect of female hormones on glycogen 
availability and adherence of C. albicans to epithe-
lial cells with yeast virulence.8 Other predisposing 
factors of vaginal candidiasis include tight nylon un-
derwear, poor ventilation and temperature increase 
and moisture of the perineum.13 Bacteria vaginosis is 
reported to be more highly prevalent among women 
using IUD.8 This is not in agreement with findings 
in this study. Oral contraceptives are also reported 
to be associated with Gardenella vaginalis.14
No finding of Trichomonas vaginalis in RTIs among 
condom users has previously been noted.15 Condoms 
are effective barriers in preventing sexually trans-
mitted disease caused by various pathogenic micro-
organisms.8 Finding of Klebsiella species in users 
with IUD method of contraception was in agreement 
with other pervious reports.8
Among controls group of noncontraceptive users, 
bacterial vaginosis and vaginal candidiasis were the 
only RTIs observed (data not shown) with higher 
prevalence of bacteria vaginosis (12.90%) compared 
with (6.50%) of vaginal candidiasis. The prevalence 
of bacteria vaginosis and vaginal candidiasis were 
higher among female contraceptive users compared 
with noncontraceptive users indicating that contra-
ceptives increase risk in acquiring bacterial vaginosis 
and vaginal candidiasis.
In conclusion, an overall prevalence of 36.90% 
of female RTIs was observed in this study. Contra-
ceptive users have a 1−7-fold increased risk of ac-
quiring female RTIs and users of IUD have higher 
prevalence of RTIs. Prevalence of RTIs decreased with 
increase duration of contraceptive use. C. albicans 
was the most prevalent agent causing RTIs among 
contraceptive users. However, bacterial vaginosis was 
the most prevalent case in RTIs among noncontra-
ceptive users. Some valuable measures to reduce 
infections associated with contraceptive use are 
advocated.
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